Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres

被引:65
作者
Jaganathan, KS
Rao, YUB
Singh, P
Prabakaran, D
Gupta, S
Jain, A
Vyas, SP [1 ]
机构
[1] Dr Hari Singh Gour Univ, Dept Pharmaceut Sci, Drug Delievery Res Lab, Sagar 470003, Madhya Pradesh, India
[2] Pasteur Inst India, Nilgiris 643103, Tamil Nadu, India
关键词
chitosan microspheres; PLGA microspheres; protein stability; tetanus toxoid; single shot vaccine;
D O I
10.1016/j.ijpharm.2004.12.026
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Stable polymeric microspheres capable of controlled release of tetanus toxoid (TT) for periods ranging from days to over months were developed. TT was stabilized, encapsulated in microspheres prepared from poly(D,L)-lactide-co-glycolide (PLGA) and chitosan by using protein stabilizer (trehalose) and its immune response was compared. The influence of co-encapsulated protein stabilizer on tetanus toxoid's stability and release from the microspheres was studied. The protein stabilizer (trehalose) prevented structural losses and aggregation of microencapsulated TT. To neutralize the acids liberated by the biodegradable lactic/glycolic acid-based polymer, we also co-incorporated into the polymer an antacid, (Mg(OH)(2)), which neutralized the acidity during degradation of the polymer and also prevented TT structural losses and aggregation. The in vitro release experiments with PLGA and chitosan microspheres were performed and the release of TT was increased up to 80-90%. The antigen integrity was investigated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by coomassie brilliant blue staining. The SDS-PAGE analysis confirmed that antigen integrity was not affected by the encapsulation procedure. In addition, the immunogenicity of PLGA and chitosan microspheres based single dose vaccine was evaluated in guinea pigs and compared with multiple doses of alum adsorbed TT. Results indicated that a single injection of PLGA and chitosan microspheres containing TT could maintain the antibody response at a level comparable to the booster injections of conventional alum adsorbed vaccines. The both PLGA and chitosan based stable vaccine formulations produced an equal immune response. Hence chitosan can be used to replace the expensive polymer PLGA. This approach should have potential application in the field of vaccine delivery. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:23 / 32
页数:10
相关论文
共 26 条
[1]   CONTROLLED-RELEASE VACCINES - BIODEGRADABLE POLYLACTIDE POLYGLYCOLIDE (PL/PG) MICROSPHERES AS ANTIGEN VEHICLES [J].
AGUADO, MT ;
LAMBERT, PH .
IMMUNOBIOLOGY, 1992, 184 (2-3) :113-125
[3]   BIODEGRADABLE MICROSPHERES AS CONTROLLED-RELEASE TETANUS TOXOID DELIVERY SYSTEMS [J].
ALONSO, MJ ;
GUPTA, RK ;
MIN, C ;
SIBER, GR ;
LANGER, R .
VACCINE, 1994, 12 (04) :299-306
[4]   DETERMINANTS OF RELEASE RATE OF TETANUS VACCINE FROM POLYESTER MICROSPHERES [J].
ALONSO, MJ ;
COHEN, S ;
PARK, TG ;
GUPTA, RK ;
SIBER, GR ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1993, 10 (07) :945-953
[5]   pH and osmotic pressure inside biodegradable microspheres during erosion [J].
Brunner, A ;
Mäder, K ;
Göpferich, A .
PHARMACEUTICAL RESEARCH, 1999, 16 (06) :847-853
[6]   Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen [J].
Chang, AC ;
Gupta, RK .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (02) :129-132
[7]   Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres [J].
Cleland, JL ;
Jones, AJS .
PHARMACEUTICAL RESEARCH, 1996, 13 (10) :1464-1475
[8]   Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues [J].
Crotts, G ;
Park, TG .
JOURNAL OF MICROENCAPSULATION, 1998, 15 (06) :699-713
[9]   BIODEGRADABLE AND BIOCOMPATIBLE POLY(DL-LACTIDE-CO-GLYCOLIDE) MICROSPHERES AS AN ADJUVANT FOR STAPHYLOCOCCAL ENTEROTOXIN-B TOXOID WHICH ENHANCES THE LEVEL OF TOXIN-NEUTRALIZING ANTIBODIES [J].
ELDRIDGE, JH ;
STAAS, JK ;
MEULBROEK, JA ;
TICE, TR ;
GILLEY, RM .
INFECTION AND IMMUNITY, 1991, 59 (09) :2978-2986
[10]   PARAMETERS AFFECTING THE IMMUNOGENICITY OF MICROENCAPSULATED TETANUS TOXOID [J].
ESPARZA, I ;
KISSEL, T .
VACCINE, 1992, 10 (10) :714-720